Equillium Inc (EQ)
1.57
+0.03
(+1.95%)
USD |
NASDAQ |
May 17, 16:00
1.57
0.00 (0.00%)
After-Hours: 20:00
Equillium Free Cash Flow: -22.66M for March 31, 2024
Free Cash Flow Chart
Historical Free Cash Flow Data
Date | Value |
---|---|
March 31, 2024 | -22.66M |
December 31, 2023 | -21.83M |
September 30, 2023 | 11.59M |
June 30, 2023 | 0.448M |
March 31, 2023 | -4.65M |
December 31, 2022 | -9.012M |
September 30, 2022 | -46.87M |
June 30, 2022 | -40.85M |
March 31, 2022 | -36.55M |
December 31, 2021 | -32.14M |
September 30, 2021 | -30.29M |
Date | Value |
---|---|
June 30, 2021 | -28.32M |
March 31, 2021 | -26.38M |
December 31, 2020 | -24.83M |
September 30, 2020 | -25.59M |
June 30, 2020 | -25.21M |
March 31, 2020 | -24.93M |
December 31, 2019 | -23.02M |
September 30, 2019 | -17.81M |
June 30, 2019 | -14.76M |
March 31, 2019 | -11.14M |
December 31, 2018 | -7.561M |
Free Cash Flow Range, Past 5 Years
-46.87M
Minimum
Sep 2022
11.59M
Maximum
Sep 2023
-22.18M
Average
-24.88M
Median
Free Cash Flow Benchmarks
Janux Therapeutics Inc | -53.26M |
Mersana Therapeutics Inc | -173.92M |
Vera Therapeutics Inc | -99.72M |
NovaBay Pharmaceuticals Inc | -4.524M |
Palatin Technologies Inc | -33.83M |
Free Cash Flow Related Metrics
Cash from Operations (Quarterly) | -8.80M |
Cash from Investing (Quarterly) | -2.831M |
Free Cash Flow Per Share (Quarterly) | -0.2502 |
Free Cash Flow to Equity (Quarterly) | -8.819M |
Free Cash Flow to Firm (Quarterly) | -8.819M |
Free Cash Flow Yield | -41.57% |